{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Central%20Admixture%20Pharmacy%20Services%2C%20Inc.","name":"Central Admixture Pharmacy Services, Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T07:03:19.241Z"},"count":3,"matches":[{"id":"0a604b0b90113071","posted_date":"2024-08-13","letter_issue_date":"2024-07-10","company_name":"Central Admixture Pharmacy Services, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/0a604b0b90113071"},{"id":"5417ba1ce68e4130","posted_date":"2024-05-21","letter_issue_date":"2024-03-25","company_name":"Central Admixture Pharmacy Services, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations IV","subject":"CGMP/Drug Products/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/5417ba1ce68e4130"},{"id":"615edbb87a883b62","posted_date":"2024-05-14","letter_issue_date":"2024-03-29","company_name":"Central Admixture Pharmacy Services, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations I","subject":"CGMP/Drug Products/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/615edbb87a883b62"}]}